InMed Pharmaceuticals

(OTC: IMLFF)
Healthcare  |  Biotechnology
0.19 0.0 0.0%
Stock Price | Nov. 19, 2019, 3:57 p.m.
0 Followers
Bid: 0.1745
Ask: 0.33
Prev. Close: 0.18764
52 Week Low: 0.1648
52 Week High: 0.627
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Special Supplement 12/24/17

26 Comments
1 year ago

Premium Mid-Week Chat - 12/13/17

1 year ago

Premium Cannabis Stocks Review - Special Supplement 12/10/17

47 Comments
1 year ago

Premium Mid-Week Chat 11/15/17

28 Comments
2 years ago

Premium Mid-Week Chat - 02/08/17

10 Comments
2 years ago

Premium Cannabis Stock Review - AM Edition 09/03/15

2 Comments
4 years ago

Premium Mid-Week Chat - 03/05/15

4 Comments
4 years ago

Free WeedStock: Breakfast Presentations

5 years ago